Cravath represented the underwriters in the offering.Albemarle Corporation represented the $1.4 billion registered secondary common stock offering. The shares were listed on the New York Stock Exchange. The transaction closed…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
